How xenohormetic compounds confer health benefits

Mild Stress and Healthy Aging: Applying Hormesis in Aging Research and Interventions

Volumn , Issue , 2008, Pages 115-138

  Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47849112973     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-6869-0_8     Document Type: Chapter

References (114)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies (Review). Anticancer Res 24(5A):2783-2840.
2. Ali RE, Rattan SI (2006) Curcumin's biphasic hormetic response on proteasome activity and heatshock protein synthesis in human keratinocytes. Ann NY Acad Sci 1067:394-399.
3. Ambra R, Rimbach G, De Pascual Teresa S, Fuchs D, Wenzel U, Daniel H, Virgili F (2006) Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutr Metab Cardiovasc Dis 16:35-43.
4. Andriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet JC, Andriantsitohaina R (1998) Natural dietary polyphenolic compounds cause endotheliumdependent vasorelaxation in rat thoracic aorta. J Nutr 128:2324-2333.
5. Anekonda TS (2006) Resveratrol - a boon for treating Alzheimer's disease? Brain Res Rev 52:316-326.
6. Anton S, Melville L, Rena G (2006) Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. Cell Signal 19:378-383.
7. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700-1705.
8. Bauer JH, Goupil S, Garber GB, Helfand SL (2004) An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc Natl Acad Sci USA 101:12980-12985.
9. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu V V, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur DG, Shaw R, J., Navas P, Puigserver P, Ingram DK, De Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342.
10. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
11. Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 76:1126-1137.
12. Bohm M, Rosenkranz S, Laufs U (2004) Alcohol and red wine: impact on cardiovascular risk (Review). Nephrol Dial Transplant 19:11-16.
13. Bove K, Lincoln DW, Tsan MF (2002) Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem Biophys Res Commun 291:1001-1005.
14. Buryanovskyy L, Fu Y, Boyd M, Ma Y, Hsieh TC, Wu JM, Zhang Z (2004) Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43:11417-11426.
15. Busby MG, Jeffcoat AR, Bloedon LT, Koch MA, Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM, Crowell JA, Zeisel SH (2002) Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75:126-136.
16. Cassidy A (2003) Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res 73:120-126.
17. Check E (2006) A votre santé: now in pill form? Nature 444:11.
18. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, Mucke L, Gan L (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kB signaling. J Biol Chem 280:40364-40374.
19. Chen Y, Tseng SH, Lai HS, Chen WJ (2004) Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136:57-66.
20. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL (2003) Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4740-4747.
21. Christen Y (2004) Ginko biloba and neurodegenerative disorders. Frontiers Biosci 9:3091-3104.
22. Christen Y, Maixent J-M (2002) What is Ginko biloba extract Egb 761? An overview - from molecular biology to clinical medicine. Cell Mol Biol 48:601-611.
23. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, De Cabo R, Sinclair DA (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392.
24. Conti B, Sanchez-Alavez M, Winsky-Sommerer R, Morale MC, Lucero J, Brownell S, Fabre V, Huitron-Resendiz S, Henriksen S, Zorrilla EP, De Lecea L, Bartfai T (2006) Transgenic mice with a reduced core body temperature have an increased life span. Science 314:825828.
25. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS (2004) Resveratrol-associated renal toxicity. Toxicol Sci 82:614-619.
26. Cullen KM, Kócsi Z, Stone J (2006) Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 27:1786-1796.
27. Das S, Alagappan VK, Bagchi D, Sharma HS, Maulik N, Das DK (2005) Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul Pharmacol 42:281-289.
28. Ehrnhoefer DE, Duennwald M, Markovic P, Wacker JL, Engemann S, Roark M, Legleiter J, Marsh JL, Thompson LM, Lindquist S, Muchowski PJ, Wanker EE (2006) Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum Mol Genet 15:2743-2751.
29. Everitt AV (2003) Food restriction, pituitary hormones and ageing. Biogerontology 4:47-50.
30. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563-7570.
31. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb JP, Marit G, Reiffers J, Mossalayi MD (2002) Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23:1327-1333.
32. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21:2281-2286.
33. Flesch M, Schwarz A, Bohm M (1998) Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 275:H1183-H1189.
34. Fontana L, Meyer TE, Klein S, Holloszy JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 101:6659-6663.
35. Frankel EN, Waterhouse AL, Kinsella JE (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103-1104.
36. Fremont L, Belguendouz L, Delpal S (1999) Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 64:2511-2521.
37. Fujiki H (2005) Green tea: health benefits as cancer preventive for humans. Chem Rec 5:119-132.
38. Fulda S, Debatin KM (2004) Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64:337-346.
39. Glaser V (1999) Billion-dollar market blossoms as botanicals take root. Nat Biotechnol 17:17-18.
40. Green NS, Foss TR, Kelly JW (2005) Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Proc Natl Acad Sci USA 102:14545-14550.
41. Grinberg LN, Newmark H, Kitrossky N, Rahamim E, Chevion M, Rachmilewitz EA (1997) Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 54:973-978.
42. Guarente L, Kenyon C (2000) Genetic pathways that regulate ageing in model organisms. Nature 408:255-262.
43. Guarente L, Picard F (2005) Calorie restriction - the SIR2 connection. Cell 120:473-482.
44. Guo Q, Zhao B, Li M, Shen S, Xin W (1996) Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim Biophys Acta 1304:210-212.
45. Guo Q, Zhao B, Shen S, Hou J, Hu J, Xin W (1999) ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta 1427:13-23.
46. Hider RC, Liu ZD, Khodr HH (2001) Metal chelation of polyphenols. Methods Enzymol 335:190-203.
47. Higdon J V, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89-143.
48. Hodgson JM (2006) Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review. Clin Exp Pharmacol Physiol 33:838-841.
49. Hollenberg NK (2006) Vascular action of cocoa flavanols in humans: the roots of the story. J Cardiovasc Pharmacol 47(Suppl. 2):S99-S102.
50. Houston MC (2005) Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog Cardiovasc Dis 47:396-449.
51. Howes MJ, Houghton PJ (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75:513-527.
52. Howes MJ, Perry NS, Houghton PJ (2003) Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 17:1-18.
53. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196.
54. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
55. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng TH, De Pinho RA, Sharpless NE, Scadden D (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443:421-426.
56. Jiang F, Dusting GJ (2003) Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects. Curr Vasc Pharmacol 1:135-156.
57. Kaliora AC, Dedoussis G V, Schmidt H (2006) Dietary antioxidants in preventing atherogenesis (Review). Atherosclerosis 187:1-17.
58. Kao YH, Hiipakka RA, Liao S (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141:980-987.
59. Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinomabearing mice. J Nutr 131:1844-1849.
60. Koo S-H, Montminy M (2006) In vino veritas: a tale of two Sirt1s? Cell 127:1091-1093.
61. Koubova J, Guarente L (2003) How does calorie restriction work? Genes Dev 17:313-321.
62. INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453-457.
63. Kuzuhara T, Sei Y, Yamaguchi K, Suganuma M, Fujiki H (2006) DNA and RNA as new binding targets of green tea catechins. J Biol Chem 281:17446-17456.
64. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol Improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127:1109-1122.
65. Lambert JD, Yang CS (2003) Mechanisms of cancer prevention by tea constituents. J Nutr 133:3262S-3267S.
66. Lamming DW, Wood JG, Sinclair DA (2004) Small molecules that regulate lifespan: evidence for xenohormesis (Review). Mol Microbiol 53:1003-1009.
67. Le Bourg E, Minois N (2005) Does dietary restriction really increase longevity in Drosophila melanogaster? Ageing Res Rev 4:409-421.
68. Le Bourg E, Rattan SIS (2006) Can dietary restriction increase longevity in all species, particularly in human beings? Introduction to a debate among experts. Biogerontology 7:123-125.
69. Leighton F, Miranda-Rottmann S, Urquiaga I (2006) A central role of eNOS in the protective effect of wine against metabolic syndrome. Cell Biochem Funct 24:291-298.
70. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106:1614-1617.
71. Li C, Allen A, Kwagh J, Doliba NM, Qin W, Najafi H, Collins HW, Matschinsky FM, Stanley CA, Smith TJ (2006) Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem 281:10214-10221.
72. + current in vascular endothelial cells. Cardiovasc Res 45:1035-1045.
73. Loh KP, Low LS, Wong WH, Zhou S, Huang SH, De Silva R, Duan W, Chou WH, Zhu YZ (2006) A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats. Neurosci Lett 398:28-33.
74. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB (2005) Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 14:46-60.
75. McCay CM, Crowell MF, Maynard LA (1935) The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 5:155-171.
76. McCullough ML, Chevaux K, Jackson L, Preston M, Martinez G, Schmitz HH, Coletti C, Campos H, Hollenberg NK (2006) Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol 47(Suppl. 2):S103-S109.
77. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443:448-452.
78. Morris BJ (2005) A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer (Review). J Hypertens 23:1285-1309.
79. Morris BJ (2007) Climate not cultivars in the NO-ing of red wines. J Hypertens 25:501-503.
80. Mukherjee D, Nissen SE, Topol EJ (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286:954-959.
81. Nigdikar SV, Williams NR, Griffin BA, Howard AN (1998) Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68:258-265.
82. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61:294-302.
83. Park OJ, Surh YJ (2004) Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150:43-56.
84. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ (2006) Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45:309-319.
85. Perez-Vizcaino F, Duarte J, Andriantsitohaina R (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols (Review). Free Radic Res 40:1054-1065.
86. Perona JS, Cabello-Moruno R, Ruiz-Gutierrez V (2006) The role of virgin olive oil components in the modulation of endothelial function (Review). J Nutr Biochem 17:429-445.
87. Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O'Neal JM, Cornwell T, Pastor I, Fridlender B (2002) Plants and human health in the twenty-first century. Trends Biotechnol 20:522-531.
88. Räthel TR, Samtleben R, Vollmar AM, Dirsch VM (2007) Activation of endothelial nitric oxide synthase by red wine polyphemols: impact of grape cultivars, growing area and the vinification process. J Hypertens 25:541-549.
89. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S (2004) Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546:121-165.
90. Renaud S, De Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523-1526.
91. Rivas M, Garay RP, Escanero JF, Cia P, Jr., Cia P, Alda JO (2002) Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132:1900-1902.
92. Sánchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Perez-Vizcaino F, Duarte J (2006) Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24:75-84.
93. Sarkar FH, Li Y (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. (Review). Cancer Metastasis Rev 21:265-280.
94. Sevov M, Elfineh L, Cavelier LB (2006) Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun 348:1047-1054.
95. Smith J V, Burdick AJ, Golik P, Khan I, Wallace D, Luo Y (2002) Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy-le-grand) 48:699-707.
96. Stefani M, Markus MA, Lin RCY, Pinese M, Dawes IA, Morris BJ (2007) The effect on resveratrol on a cell model of human aging. Ann NY Acad Sci (in press).
97. Szewczuk LM, Forti L, Stivala LA, Penning TM (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem 279:22727-22737.
98. Tessitore L, Davit A, Sarotto I, Caderni G (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression. Carcinogenesis 16:1619-1622.
99. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY, Chen Y (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10:2190-2202.
100. Turner R (2003) Tuned for longer life. Nature 423:125.
101. Urpi-Sarda M, Jauregui O, Lamuela-Raventos RM, Jaeger W, Miksits M, Covas MI, Andres-Lacueva C (2005) Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77:3149-3155.
102. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16:296-300.
103. Visioli F, Galli C (1994) Oleuropein protects low density lipoprotein from oxidation. Life Sci 55:1965-1971.
104. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM (2003) Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72:2219-2233.
105. Walford RL, Mock D, Verdery R, MacCallum T (2002) Calorie restriction in Biosphere 2: alterations in physiological, haematological, and biochemical parameters in humans restricted for a 2-year period. J Gerontol 57 A: B211-B224.
106. Walle T, Hsieh F, De Legge MH, Oatis JE, Jr., Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382.
107. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-1658.
108. Wallerath T, Li H, Godtel-Ambrust U, Schwarz PM, Forstermann U (2005) A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12:97-104.
109. Wang ZY, Huang MT, Lou YR, Xie JG, Reuhl KR, Newmark HL, Ho CT, Yang CS, Conney AH (1994) Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7, 12-dimethylbenz[a]anthracen e-initiated SKH-1 mice. Cancer Res 54:3428-3435.
110. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686-689.
111. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, Van Breemen RB (2002) Human, rat, and mouse metabolism of resveratrol. Pharm Res 19:1907-1914.
112. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, Wierzbicki M, Verbeuren TJ, Cohen RA (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55:2180-2191.
113. Zhang SM, Lee IM, Manson JE, Cook NR, Willett WC, Buring JE (2007) Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol 165:667-676.
114. Zimmermann M, Colciaghi F, Cattabeni F, Di Luca M (2002) Ginko biloba extract: from molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol 48:613-623.